Get help Advice and information leaflets Switching to Biosimilars Have you been asked to switch from a biologic medicine to a new biosimilar? Here we have some useful information for everyone who wants to know more. When your doctor, nurse or specialist wants to talk to you about changing your medication it is natural to want to understand the reasons why. Some patients are being asked to 'switch' from biological medicines to biosimilar medicines, but do you know the difference? For the past year, the Patients Association has been working with patients, clinicians and pharmacists to create a suite of resources to help you understand why you might be asked to switch to biosimilar medication, what biosimilars are, and how the switch should work for you. We also encourage you to ask questions, whether you are talking to your doctor, nurse or specialist, and provide you with details of specialist organisations should you need more specific help and information. Resources Please download and read our leaflet on biosimilars here. You can watch our information video below (or click here to watch with subtitles). Further information If you want to find out more about biosimilars, you might find the following list of organisations useful.(The Patients Association is not responsible for information on external sites) NHSInformation on biosimilars National Rheumatoid Arthritis Society (NRAS)Information on biosimilarsHelpline: 0800 298 7650Email: [email protected] Crohns and Colitis UKInformation on biosimilar drugs for adalimumab (Humira)Helpline: 0300 222 5700Email: [email protected]s.org.uk Birdshot Uveitis Society (BUS)Biosimilars to Humira (adalimumab) - Q&AsEmail: [email protected] The Psoriasis Associationpsoriasis-association.org.uk Tel: 01604 251 620Email: [email protected] Diabetes UKDiabetes UK statement on biosimilar insulinTel: 0345 123 2399Email: [email protected] JDRF (Type 1 diabetes charity)jdrf.org.uk information on biosimilar insulin (published September 2015)Tel: 020 7713 2030Email: [email protected] National Ankylosing Spondylitis Society (NASS)NASS biosimilar informationHelpline: 020 8741 1515 Lymphoma ActionInformation on biosimilar lymphoma medicationHelpline: 0808 808 5555Email: [email protected] The Switching to Biosimilars project has been developed by the Patients Association, supported through sponsorship from Novo Nordisk and Amgen, and an unrestricted educational grant from Sanofi. No companies had any influence on the development of the materials but they have commented on the final versions.